The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Financial toxicity of front-line platinum etoposide plus atezolizumab versus durvalumab in extensive-stage small-cell (ES-SCLC) lung cancer.
 
Bradley Harrison
No Relationships to Disclose
 
Nicole Keith
No Relationships to Disclose
 
Allison Verbyla
No Relationships to Disclose
 
Kathryn Finch Mileham
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; G1 Therapeutics; Mirati Therapeutics; Regeneron
Speakers' Bureau - Merck